By Sierra Jackson ( July 30, 2020, 6:46 PM EDT) -- Cerevel Therapeutics Inc., a Pfizer joint venture focusing on neurological diseases, said Thursday that it was being taken public by a blank check company backed by Perceptive Advisors in a $780 million merger advised on by Kirkland, Goodwin and Ropes & Gray....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.